Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by quest13on Aug 22, 2012 11:28am

209 Views

Post# 20246575

RE: RE: RE: RE: RE: RE: RE: RE: RE: Talkathon...

Risky,

I have been following your points on RVX and trying to ignore your gratuitous jabs at San Fran.

I like the comments you make about the stock and I am sure that San Fran and everyone else on the board likes your thoughts on RVX itself.

San fran has a number of times also mentionned that he appreciates your thoughts on the company as well.

What bothers me is that while I read San Fran's posts as well, and he appears to try to restrain his reactions to your jabs, the jabs detract from your otherwise worthwhile thoughts.

I am sure that others on the board would also like to see you continue to post without personal attacks.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario